Traveling while on home dialysis can be intimidating, but it can also be liberating and an important feature of utilizing home dialysis modalities. In this course, we’ll look at encouraging patients to try traveling, the role of the nurse in helping plan ahead for dialysis needs, and helpful information to relay to the patient. Both home hemodialysis and peritoneal dialysis modalities will be discussed.
After taking this course, participants will be able to:
- Identify planning needs for patients traveling on dialysis
- Describe the contents of the NXRX Travel Form for Home HD Patients
- Create awareness of timelines and logistics patients experience when traveling
- List three temporary ways a PD prescription might be modified to make traveling easier for the patient
Audience
Nurses and Dialysis Technicians
Contact Hour Approval
This continuing nursing education activity was approved by Medical Education Institute, approved by the California Board of Registered Nursing, Provider #CEP-17088, for 1 contact hour.
Author Information
Jane Hafner, RN, BSN, and Joshua Dipzinski, RN, BSN on behalf of Medical Education Institute
Jane Hafner, who holes a BA in Psychology and a BS in Nursing, has been a nephrology nurse for more than 45 years. She now does nephrology consulting after retiring. She is a member of ANNA and the Health Policy representative for the Heart of America ANNA chapter.
Joshua Dipzinski, RN, BSN, started as a hemodialysis tech before going on to receive this BSN from Western Michigan University in 2012. While running four home programs in the suburbs of Chicago, he was able to learn about intermittent dialysis and low impact icodextrin usage. He is now the CEO and Registered Nurse for Premier Dialysis of Michigan.
Accreditation for this course expires October 31, 2026.
It is the responsibility of the applicant to determine if these CE contact hours will be accepted by a particular licensing organization.
Conflicts of interest
The development of this course was funded through an unrestricted educational grant from Fresenius Kidney Care and NxStage Medical.
No conflicts of interest were disclosed.
